Romain Veyron-Churlet

Dr. Romain Veyron-Churlet

Université de Lille, CNRS UMR8204, INSERM U1019, CHU Lille, Centre d’Infection et d’Immunité de Lille, Institut Pasteur de Lille, 59000 Lille, France
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2013 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
RWRegina Wilson
Regina Wilson
PKPradeep Kumar
Pradeep Kumar
VPVijay Parashar
Vijay Parashar
CVCatherine Vilchèze
Catherine Vilchèze
RVRomain Veyron-Churlet
Romain Veyron-Churlet
DADavid Alland
David Alland
Thiophene compounds kill M. tuberculosis by inhibiting Pks13, demonstrating that the enzyme catalyzes a critical step in biosynthesis of mycolic acids in vivo. We report a new class of thiophene (TP) compounds that kill Mycobacterium tuberculosis by the previously uncharacterized mechanism of Pks13 inhibition. An F79S mutation near the catalytic Ser55 site in Pks13 conferred TP resistance in M. tuberculosis. Overexpression of wild-type Pks13 resulted in TP resistance, and overexpression of the Pks13F79S mutant conferred high resistance. In vitro, TP inhibited fatty acyl–AMP loading onto Pks13. TP inhibited mycolic acid biosynthesis in wild-type M. tuberculosis, but it did so to a much lesser extent in TP-resistant M. tuberculosis. TP treatment was bactericidal and equivalent to treatment with the first-line drug isoniazid, but it was less likely to permit emergent resistance. Combined isoniazid and TP treatment resulted in sterilizing activity. Computational docking identified a possible TP-binding groove within the Pks13 acyl carrier protein domain. This study confirms that M. tuberculosis Pks13 is required for mycolic acid biosynthesis, validates it as a druggable target and demonstrates the therapeutic potential of simultaneously inhibiting multiple targets in the same biosynthetic pathway.

15 March 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LGLaure Guenin-Macé
Laure Guenin-Macé
RVRomain Veyron-Churlet
Romain Veyron-Churlet
MTMaria-Isabel Thoulouze
Maria-Isabel Thoulouze
GRGuillaume Romet-Lemonne
Guillaume Romet-Lemonne
HHHui Hong
Hui Hong
CDCaroline Demangel
Caroline Demangel
Mycolactone is a diffusible lipid secreted by the human pathogen Mycobacterium ulcerans, which induces the formation of open skin lesions referred to as Buruli ulcers. Here, we show that mycolactone operates by hijacking the Wiskott-Aldrich syndrome protein (WASP) family of actin-nucleating factors. By disrupting WASP autoinhibition, mycolactone leads to uncontrolled activation of ARP2/3-mediated assembly of actin in the cytoplasm. In epithelial cells, mycolactone-induced stimulation of ARP2/3 concentrated in the perinuclear region, resulting in defective cell adhesion and directional migration. In vivo injection of mycolactone into mouse ears consistently altered the junctional organization and stratification of keratinocytes, leading to epidermal thinning, followed by rupture. This degradation process was efficiently suppressed by coadministration of the N-WASP inhibitor wiskostatin. These results elucidate the molecular basis of mycolactone activity and provide a mechanism for Buruli ulcer pathogenesis. Our findings should allow for the rationale design of competitive inhibitors of mycolactone binding to N-WASP, with anti–Buruli ulcer therapeutic potential.

30 September 2004 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
RVRomain Veyron-Churlet
Romain Veyron-Churlet
OGOlivier Guerrini
Olivier Guerrini
LMLionel Mourey
Lionel Mourey
MDMamadou Daffé
Mamadou Daffé
DZDidier Zerbib
Didier Zerbib
Summary: Despite the existence of efficient chemotherapy, tuberculosis remains a leading cause of mortality worldwide. New drugs are urgently needed to reduce the potential impact of the emergence of multidrug‐resistant strains of the causative agent Mycobacterium tuberculosis (Mtb). The front‐line antibiotic isoniazid (INH), and several other drugs, target the biosynthesis of mycolic acids and especially the Fatty Acid Synthase‐II (FAS‐II) elongation system. This biosynthetic pathway is essential and specific for mycobacteria and still represents a valuable system for the search of new anti‐tuberculous agents. Several data, in the literature, suggest the existence of protein–protein interactions within the FAS‐II system. These interactions themselves might serve as targets for a new generation of drugs directed against Mtb. By using an extensive in vivo yeast two‐hybrid approach and in vitro co‐immunoprecipitation, we have demonstrated the existence of both homotypic and heterotypic interactions between the known components of FAS‐II. The condensing enzymes KasA, KasB and mtFabH interact with each other and with the reductases MabA and InhA. Furthermore, we have designed and constructed point mutations of the FAS‐II reductase MabA, able to disrupt its homotypic interactions and perturb the interaction pattern of this protein within FAS‐II. Finally, we showed by a transdominant genetic approach that these mutants are dominant negative in both non‐pathogenic and pathogenic mycobacteria. These data allowed us to draw a dynamic model of the organization of FAS‐II. They also represent an important step towards the design of a new generation of anti‐tuberculous agents, as being inhibitors of essential protein–protein interactions.

1 April 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RVRomain Veyron-Churlet
Romain Veyron-Churlet
IZIsabelle Zanella-Cléon
Isabelle Zanella-Cléon
MCMartin Cohen-Gonsaud
Martin Cohen-Gonsaud
VMVirginie MOLLE
Virginie MOLLE
LKLaurent Kremer
Laurent Kremer
Mycolic acids are key cell wall components for the survival, pathogenicity, and antibiotic resistance of the human tubercle bacillus. Although it was thought that Mycobacterium tuberculosis tightly regulates their production to adapt to prevailing environmental conditions, the molecular mechanisms governing mycolic acid biosynthesis remained extremely obscure. Meromycolic acids, the direct precursors of mycolic acids, are synthesized by a type II fatty acid synthase from acyl carrier protein-bound substrates that are extended iteratively, with a reductive cycle in each round of extension, the second step of which is catalyzed by the essential beta-ketoacyl-acyl carrier protein reductase, MabA. In this study, we investigated whether post-translational modifications of MabA might represent a strategy employed by M. tuberculosis to regulate mycolic acid biosynthesis. Indeed, we show here that MabA was efficiently phosphorylated in vitro by several M. tuberculosis Ser/Thr protein kinases, including PknB, as well as in vivo in mycobacteria. Mass spectrometric analyses using LC-ESI/MS/MS and site-directed mutagenesis identified three phosphothreonines, with Thr(191) being the primary phosphor-acceptor. A MabA_T191D mutant, designed to mimic constitutive phosphorylation, exhibited markedly decreased ketoacyl reductase activity compared with the wild-type protein, as well as impaired binding of the NADPH cofactor, as demonstrated by fluorescence spectroscopy. The hypothesis that phosphorylation of Thr(191) alters the enzymatic activity of MabA, and subsequently mycolic acid biosynthesis, was further supported by the fact that constitutive overexpression of the mabA_T191D allele in Mycobacterium bovis BCG strongly impaired mycobacterial growth. Importantly, conditional expression of the phosphomimetic MabA_T191D led to a significant inhibition of de novo biosynthesis of mycolic acids. This study provides the first information on the molecular mechanism(s) involved in mycolic acid regulation through Ser/Thr protein kinase-dependent phosphorylation of a type II fatty acid synthase enzyme.

7 July 2016 in Scientific Reports
Verified
Journal Article
Open access
CQChristophe J. Queval
Christophe J. Queval
OSOk-Ryul Song
Ok-Ryul Song
NDNathalie Deboosère
Nathalie Deboosère
VDVincent Delorme
Vincent Delorme
ADAnne-Sophie Debrie
Anne-Sophie Debrie
PBPriscille Brodin
Priscille Brodin
Mycobacterium tuberculosis is a successful intracellular pathogen. Numerous host innate immune responses signaling pathways are induced upon mycobacterium invasion, however their impact on M. tuberculosis replication is not fully understood. Here we reinvestigate the role of STAT3 specifically inside human macrophages shortly after M. tuberculosis uptake. We first show that STAT3 activation is mediated by IL-10 and occurs in M. tuberculosis infected cells as well as in bystander non-colonized cells. STAT3 activation results in the inhibition of IL-6, TNF-α, IFN-γ and MIP-1β. We further demonstrate that STAT3 represses iNOS expression and NO synthesis. Accordingly, the inhibition of STAT3 is detrimental for M. tuberculosis intracellular replication. Our study thus points out STAT3 as a key host factor for M. tuberculosis intracellular establishment in the early stages of macrophage infection.

8 May 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CVCatherine Vilchèze
Catherine Vilchèze
VMVirginie MOLLE
Virginie MOLLE
SCSéverine Carrère-Kremer
Séverine Carrère-Kremer
JLJade Leiba
Jade Leiba
LMLionel Mourey
Lionel Mourey
LKLaurent Kremer
Laurent Kremer
Mycobacterium tuberculosis bacilli display two signature features: acid-fast staining and the capacity to induce long-term latent infections in humans. However, the mechanisms governing these two important processes remain largely unknown. Ser/Thr phosphorylation has recently emerged as an important regulatory mechanism allowing mycobacteria to adapt their cell wall structure/composition in response to their environment. Herein, we evaluated whether phosphorylation of KasB, a crucial mycolic acid biosynthetic enzyme, could modulate acid-fast staining and virulence. Tandem mass spectrometry and site-directed mutagenesis revealed that phosphorylation of KasB occurred at Thr334 and Thr336 both in vitro and in mycobacteria. Isogenic strains of M. tuberculosis with either a deletion of the kasB gene or a kasB_T334D/T336D allele, mimicking constitutive phosphorylation of KasB, were constructed by specialized linkage transduction. Biochemical and structural analyses comparing these mutants to the parental strain revealed that both mutant strains had mycolic acids that were shortened by 4–6 carbon atoms and lacked trans-cyclopropanation. Together, these results suggested that in M. tuberculosis, phosphorylation profoundly decreases the condensing activity of KasB. Structural/modeling analyses reveal that Thr334 and Thr336 are located in the vicinity of the catalytic triad, which indicates that phosphorylation of these amino acids would result in loss of enzyme activity. Importantly, the kasB_T334D/T336D phosphomimetic and deletion alleles, in contrast to the kasB_T334A/T336A phosphoablative allele, completely lost acid-fast staining. Moreover, assessing the virulence of these strains indicated that the KasB phosphomimetic mutant was attenuated in both immunodeficient and immunocompetent mice following aerosol infection. This attenuation was characterized by the absence of lung pathology. Overall, these results highlight for the first time the role of Ser/Thr kinase-dependent KasB phosphorylation in regulating the later stages of mycolic acid elongation, with important consequences in terms of acid-fast staining and pathogenicity. Acid-fast staining has been used since 1882 as the hallmark diagnostic test for detecting Mycobacterium tuberculosis, the causative agent of tuberculosis. It has been attributed to the presence of a waxy cell envelope, and primarily to its key components, mycolic acids. Here, we report a new mechanism of regulation in which phosphorylation of KasB, involved in the completion of full-length mycolic acids, leads to shortened mycolic acids and loss of acid-fast staining. Moreover, a M. tuberculosis mutant strain mimicking constitutive phosphorylation of KasB is severely attenuated for growth in both immunocompetent and immunosuppressed mice and fails to cause mortality and pathophysiological symptoms. These results emphasize the critical role of kinase-dependent phosphorylation in the pathogenesis of M. tuberculosis by controlling the mycolic acid chain length. Our study demonstrates the importance of a regulatory mechanism governing acid-fastness and virulence of M. tuberculosis.